TABLE.
b-ELISA | PRNT80 | ||||
---|---|---|---|---|---|
Serum sample |
Inhibition 6B6C-1 (%) |
Inhibition 3.1112g (%) |
WNV | SLEV | Flavivirus type |
HSA1 | 79.3 | 33.5 | 20 | <10 | WNV |
HSA2 | 71.3 | 18.2 | NT | NT | UN |
HSA3 | 61.9 | 15.9 | NT | NT | UN |
HSA4 | 69.2 | 47.1 | 320 | 40 | WNV |
HSA5 | 72 | 2.3 | NT | NT | UN |
HSA6 | 38.1 | 17.9 | NT | NT | UN |
HSA7 | 69.2 | 65.7 | <10 | <10 | UN |
HSA8 | 57.6 | 15.5 | NT | NT | UN |
HSA9 | 75.2 | 18.18 | NT | NT | UN |
HSA10 | 35.6 | 53.4 | <10 | <10 | UN |
HSB11 | 67.5 | 58.7 | 40 | <10 | WNV |
HSB12 | 53.5 | 19.7 | NT | NT | UN |
HSB13 | 54.3 | 11.3 | NT | NT | UN |
HSB14 | 64.6 | 33.8 | NT | NT | UN |
HSB15 | 66.4 | 19.1 | NT | NT | UN |
HSB16 | 63.4 | 23.2 | NT | NT | UN |
HSB17 | 36.8 | 20.8 | NT | NT | UN |
HSB18 | 75.7 | 13.8 | NT | NT | UN |
HSB19 | 61 | 12.4 | NT | NT | UN |
HSB20 | 74.4 | 22.8 | NT | NT | UN |
HSB21 | 55 | 27.3 | NT | NT | UN |
HSB22 | 62.1 | 26.1 | NT | NT | UN |
HSB23 | 68 | 19.1 | NT | NT | UN |
CSA1 | 78.5 | 75.4 | 80 | <10 | WNV |
CSA2 | 54.3 | 10.5 | NT | NT | UN |
CSA: chicken serum site A; HAS: horse serum site A; HSB: horse serum site B; NT: not tested; PRNT80: 80% plaque-reduction neutralisation test; UN: undetermined.